Clinical study on oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion
|更新时间:2022-07-10
|
Clinical study on oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion
Shanghai Journal of Traditional Chinese MedicineVol. 56, Issue 2, Pages: 45-48(2022)
YUAN Yifan,ZHU Rui,GONG Yabin,et al.Clinical study on oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(02):45-48.
YUAN Yifan,ZHU Rui,GONG Yabin,et al.Clinical study on oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(02):45-48. DOI: 10.16305/j.1007-1334.2022.2101128.
Clinical study on oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion
Objective,2,To observe the clinical efficacy of oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe in treating lung cancer with pleural effusion.,Methods,2,Sixty-four patients of lung cancer with pleural effusion were randomly divided into the treatment group and control group, 32 cases in each group. The control group was treated with conventional western medicine, and the treatment group was treated with Linggui Zhugan Decoction by oral administration and Xiaoshui Recipe by external application based on the treatment for the control group. The treatment course was 7 days in both groups. The clinical efficacy was observed, the changes of Chinese medical syndrome scores, immune indexes, inflammatory factors and tumor indexes were compared, as well as the puncture and drainage of pleural effusion and the use of diuretics.,Results,2,①During the trial, two cases in the treatment group and two cases in the control group fell off, finally 60 cases completed the trail, among 30 cases in the treatment group and 30 cases in the control group. ②The total effective rates of the treatment group and the control group were 86.7% and 60.0% respectively. The clinical efficacy of the treatment group was better than that of the control group (,P,<,0.05). ③Compared with those before treatment, the total score of Chinese medical syndrome and the scores of cough, shortness of breath, chest tightness and mental fatigue were decreased in the treatment group after treatment (,P,<,0.05), while the total score of Chinese medical syndrome and the score of shortness of breath were increased in the control group (,P,<,0.05). After treatment, the total score of Chinese medical syndrome and the scores of cough, shortness of breath, chest tightness and mental fatigue in the treatment group were lower than those in the control group (,P,<,0.05). ④Compared with those before treatment, the levels of CD3,+, and CD4,+, in peripheral blood were increased and the levels of interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), malignant tumor specific growth factor (TSGF) and carcinoembryonic antigen (CEA) were decreased in the treatment group (,P,<,0.05), but there were no statistically significant differences on the immune, tumor and inflammatory factors in the control group after treatment (,P,>,0.05). After treatment, the levels of CD3,+, and CD4,+, in the treatment group were higher than those in the control group, and the levels of IL-2 and IL-6 in the treatment group were lower than those in the control group (,P,<,0.05). ⑤The rate of pleural effusion puncture and drainage in the treatment group was lower than that in the control group (,P,<,0.05), and there was no statistically significant difference in the use of diuretics between the two groups (,P,>,0.05).,Conclusion,2,Oral administration of modified Linggui Zhugan Decoction combined with external application of Xiaoshui Recipe shows good efficacy in treating lung cancer with pleural effusion, which can effectively reduce pleural effusion and improve the clinical symptoms of patients.
关键词
肺癌胸腔积液苓桂术甘汤消水贴中医外治临床试验
Keywords
lung cancerpleural effusionLinggui Zhugan DecoctionXiaoshui Recipeexternal application of Chinese medicineclinical trial
PORCEL J M, GASOL A, BIELSA S, et al. Clinical features and survival of lung cancer patients with pleural effusions[J]. Respirology, 2015, 20(4): 654-659.
MURUGANANDAN S, AZZOPARDI M, FITZGERALD D B, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters(AMPLE-2): an open-label randomised trial[J]. Lancet Respir Med, 2018, 6(9): 671-680.
BHATNAGAR R, KEENAN E K, MORLEY A J, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion[J]. N Engl J Med, 2018, 378(14): 1313-1322.
Effect of wearable ankle point stimulator combined with comprehensive rehabilitation training on foot and ankle function in children with spastic hemiplegic cerebral palsy
Clinical study on treatment of severe non‑proliferative diabetic retinopathy with modified Taohong Siwu Decoction and laser therapy
Distribution rule of TCM syndrome elements in chronic obstructive pulmonary disease with lung cancer
Discussion on traditional Chinese medicine pathogenesis of brain metastases from lung cancer based on theory of “lung⁃brain correlation”
Clinical study on the treatment of lower limb venous ulcer of qi deficiency and blood stasis syndrome with Modified Qilong Quyu Mixture plus external treatment and conditioning
Related Author
No data
Related Institution
Shanghai University of Traditional Chinese Medicine
Yangzhi Rehabilitation Hospital, Tongji University
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine